{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-15",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "San Diego",
      "state": "CA",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "72651",
      "recalling_firm": "Ameditech Inc",
      "address_1": "9940 Mesa Rim Rd",
      "address_2": "N/A",
      "postal_code": "92121-2910",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide Distribution.",
      "recall_number": "Z-0518-2016",
      "product_description": "ProScreen 10 Panel Dip Card, Item No. PSD-10MOX, PSD-10MOB, PSD-10MMO300",
      "product_quantity": "2,452 kits",
      "reason_for_recall": "Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.",
      "recall_initiation_date": "20151116",
      "center_classification_date": "20151224",
      "termination_date": "20161109",
      "report_date": "20151230",
      "code_info": "141963  142196  143166  143475  143827  152038  152172  152218  152323  152393  152394  152870  153362"
    }
  ]
}